2VM-29198-42933
4 vaccinations
3 coded responses
31 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 211 / MD
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Registered in v-safe
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-29
- 2021-01-03
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Left supraclavicular lymph node swelling. Same arm as the injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Good · Site: PainFree text: Left tender supraclavicular lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-13
- 2021-02-22
- 2021-04-13
- 2021-07-10
-
2021-09-04
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-11
- 2021-10-16
- 2021-12-04
- 2022-03-05
- 2022-09-06
-
2022-09-28
Dose 4 — Pfizer-BioNTech
- 2022-09-28
- 2022-09-29
-
2022-09-30
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-04
- 2022-10-07
- 2022-10-18
- 2022-10-28
- 2022-11-02
- 2022-11-11
-
2022-12-28
Survey response — 3 months, dose 4MedDRA: Pre-eclampsia, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Severe pre-eclampsia during and after pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-04 | Pfizer-BioNTech | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | priority 2/3 | |
| 2022-12-28 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Left supraclavicular lymph node swelling. Same arm as the injection
Systemic reaction (other): Left tender supraclavicular lymph node
Release 12 — 3 months, dose 4
Symptoms: Severe pre-eclampsia during and after pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release